Core Insights - Meinian Health's stock price is reported at 5.73 yuan, down 2.39% from the previous trading day, with a trading volume of 728 million yuan and a turnover rate of 3.25% [1] - Meinian Health is a leading provider of health examination and management services in China, focusing on preventive medicine [1] - The company has been actively promoting the commercialization of AI technology in health management, including personalized package generation, AI-assisted diagnosis, and post-examination health tracking services [1] Company Developments - The recently launched private AI health manager "Health Xiaomei" has been implemented in 109 health examination centers, generating over 390,000 health examination reports [1] - Through the "1+X" personalized examination model, combined with AI technology, the company has improved screening accuracy, detecting 262,800 cancer diagnoses from 2023 to July 2025, with most cases being early-stage [1] Market Activity - On August 21, the net inflow of main funds was 12.3461 million yuan, with a cumulative net inflow of 416 million yuan over the past five days, indicating high market interest in the stock [1]